Vascular calcification: Pathophysiology and risk factors

Current Hypertension Reports

Volumn 14, Issue 3, 2012, Pages 228-237

  Chen, Neal X ^a   Moe, Sharon M ^a  

^a INDIANA UNIVERSITY   (United States)

Author keywords

Chronic kidney disease (CKD); Diabetes; Hypertension; Nontraditional risk factors; Traditional risk factors; Vascular calcification

Indexed keywords

ADVANCED GLYCATION END PRODUCT; BONE MORPHOGENETIC PROTEIN 2; BONE MORPHOGENETIC PROTEIN 4; CAPTOPRIL; FIBROBLAST GROWTH FACTOR 23; PHOSPHATE BINDING AGENT; SPIRONOLACTONE; TRANSCRIPTION FACTOR RUNX2;

ARTERY CALCIFICATION; ARTERY INTIMA; ARTERY MEDIA; ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; BONE MINERALIZATION; CHRONIC KIDNEY DISEASE; COMPUTER ASSISTED TOMOGRAPHY; CORONARY ARTERY CALCIFICATION; DIABETES MELLITUS; DISEASE ACTIVITY; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE SEVERITY; DYSLIPIDEMIA; HUMAN; HYPERCALCEMIA; HYPERPHOSPHATEMIA; HYPERTENSION; INFLAMMATION; LIPID OXIDATION; MINERAL METABOLISM; MORTALITY; NONHUMAN; OXIDATIVE STRESS; PATHOGENESIS; PATHOPHYSIOLOGY; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PREVALENCE; PROTEIN EXPRESSION; PROTEIN FUNCTION; RISK ASSESSMENT; RISK FACTOR; SMOOTH MUSCLE FIBER; VASCULAR SMOOTH MUSCLE;

AGE FACTORS; CORONARY VESSELS; DIABETES COMPLICATIONS; GLYCOSYLATION END PRODUCTS, ADVANCED; HUMANS; HYPERTENSION; INFLAMMATION; KIDNEY FAILURE, CHRONIC; MINERALS; OXIDATIVE STRESS; RENAL INSUFFICIENCY, CHRONIC; RISK FACTORS; VASCULAR CALCIFICATION;

EID: 84865688452     PISSN: 15226417     EISSN: 15343111     Source Type: Journal    
DOI: 10.1007/s11906-012-0265-8     Document Type: Article

References (100)

1. Moe SM, Chen NX. Mechanisms of vascular calcification in chronic kidney disease. J Am Soc Nephrol. 2008;19(2):213-6. (Pubitemid 351240642)
2. Ibanez B, Badimon JJ, Garcia MJ. Diagnosis of atherosclerosis by imaging. Am J Med. 2009;122(1 Suppl):S15-25.
3. Moe SM, Chen NX. Pathophysiology of vascular calcification in chronic kidney disease. Circ Res. 2004;95(6):560-7. (Pubitemid 39274370)
4. Proudfoot D, Shanahan CM, Weissberg PL. Vascular calcification: new insights into an old problem [editorial; comment]. J Pathol. 1998;185(1):1-3.
5. Lehto S, Niskanen L, Suhonen M, Ronnemaa T, Laakso M. Medial artery calcification. A neglected harbinger of cardiovascular complications in non-insulin-dependent diabetes mellitus. Arterioscler Thromb Vasc Biol. 1996;16(8):978-83. (Pubitemid 26266896)
6. London GM, Guerin AP, Marchais SJ, Metivier F, Pannier B, Adda H. Arterial media calcification in end-stage renal disease: impact on all-cause and cardiovascular mortality. Nephrol Dial Transplant. 2003;18(9):1731-40. (Pubitemid 37098542)
7. Moe SM, Chen NX. Calciphylaxis and vascular calcification: a continuum of extra-skeletal osteogenesis. Pediatr Nephrol. 2003;18:969-75. (Pubitemid 37236207)
8. Raggi P, Gongora MC, Gopal A, Callister TQ, Budoff M, Shaw LJ. Coronary artery calcium to predict all-cause mortality in elderly men and women. J Am Coll Cardiol. 2008;52(1):17-23. (Pubitemid 351858598)
9. Block, G.A., P. Raggi, A. Bellasi, L. Kooienga, and D.M. Spiegel, Mortality effect of coronary calcification and phosphate binder choice in incident hemodialysis patients. Kidney Int, 2007.
10. Mehrotra R, Budoff M, Hokanson JE, Ipp E, Takasu J, Adler S. Progression of coronary artery calcification in diabetics with and without chronic kidney disease. Kidney Int. 2005;68(3):1258-66. (Pubitemid 43246445)
11. Block GA, Spiegel DM, Ehrlich J, Mehta R, Lindbergh J, Dreisbach A, et al. Effects of sevelamer and calcium on coronary artery calcification in patients new to hemodialysis. Kidney Int. 2005;68(4):1815-24. (Pubitemid 43169927)
12. Moe SM, O'Neill KD, Reslerova M, Fineberg N, Persohn S, Meyer CA. Natural history of vascular calcification in dialysis and transplant patients. Nephrol Dial Transplant. 2004;19 (9):2387-93. (Pubitemid 39214138)
13. Schwarz U, Buzello M, Ritz E, Stein G, Raabe G, Wiest G, et al. Morphology of coronary atherosclerotic lesions in patients with end-stage renal failure. Nephrology, Dialysis, Transplantation. 2000;15(2):218-23. (Pubitemid 30064276)
14. Gross ML, Meyer HP, Ziebart H, Rieger P, Wenzel U, Amann K, et al. Calcification of coronary intima and media: immunohistochemistry, backscatter imaging, and x-ray analysis in renal and nonrenal patients. Clin J Am Soc Nephrol. 2007;2(1):121-34.
15. Nakamura S, Ishibashi-Ueda H, Niizuma S, Yoshihara F, Horio T, Kawano Y. Coronary calcification in patients with chronic kidney disease and coronary artery disease. Clin J Am Soc Nephrol. 2009;4(12):1892-900.
16. Moe SM, O'Neill KD, Duan D, Ahmed S, Chen NX, Leapman SB, et al. Medial artery calcification in ESRD patients is associated with deposition of bone matrix proteins. Kidney Int. 2002;61 (2):638-47. (Pubitemid 34102607)
17. Allison MA, Hsi S, Wassel CL, Morgan C, Ix JH, Wright CM, et al. Calcified atherosclerosis in different vascular beds and the risk of mortality. Arterioscler Thromb Vasc Biol. 2012;32(1):140-6.
18. Chen NX, O'Neill KD, Chen X, Moe SM. Annexin-mediated matrix vesicle calcification in vascular smooth muscle cells. J Bone Miner Res. 2008;23(11):1798-805.
19. Shroff RC, McNair R, Figg N, Skepper JN, Schurgers L, Gupta A, et al. Dialysis accelerates medial vascular calcification in part by triggering smooth muscle cell apoptosis. Circulation. 2008;118(17):1748-57.
20. Chen, N.X., F. Kircelli, K.D. O'Neill, X. Chen, and S.M. Moe, Verapamil inhibits calcification and matrix vesicle activity of bovine vascular smooth muscle cells. Kidney Int, 2010. 77(5): p. 436-42. This study provides evidence of the importance of extracellular calcium in MV activity and calcification.
21. Barreto DV, Barreto Fde C, Carvalho AB, Cuppari L, Draibe SA, Dalboni MA, et al. Association of changes in bone remodeling and coronary calcification in hemodialysis patients: a prospective study. Am J Kidney Dis. 2008;52(6):1139-50.
22. Ketteler M, Biggar PH. Review article: getting the balance right: assessing causes and extent of vascular calcification in chronic kidney disease. Nephrology (Carlton). 2009;14(4):389-94.
23. Everhart JE, Pettitt DJ, Knowler WC, Rose FA, Bennett PH. Medial arterial calcification and its association with mortality and complications of diabetes. Diabetologia. 1988;31(1):16-23. (Pubitemid 18077567)
24. Mehrotra R, Budoff M, Christenson P, Ipp E, Takasu J, Gupta A, et al. Determinants of coronary artery calcification in diabetics with and without nephropathy. Kidney Int. 2004;66(5):2022-31.
25. Chertow, G.M., P. Raggi, S. Chasan-Taber, J. Bommer, H. Holzer, and S.K. Burke, Determinants of progressive vascular calcification in haemodialysis patients. Nephrol Dial Transplant, 2004.
26. Orakzai SH, Nasir K, Blaha M, Blumenthal RS, Raggi P. Non- HDL cholesterol is strongly associated with coronary artery calcification in asymptomatic individuals. Atherosclerosis. 2009;202(1):289-95.
27. Henein MY, Owen A. Statins moderate coronary stenoses but not coronary calcification: results from meta-analyses. Int J Cardiol. 2011;153(1):31-5.
28. Raggi P, Cooil B, Callister TQ. Use of electron beam tomography data to develop models for prediction of hard coronary events. Am Heart J. 2001;141(3):375-82. (Pubitemid 32200265)
29. Budoff MJ, Rader DJ, Reilly MP, Mohler 3rd ER, Lash J, Yang W, et al. Relationship of estimated GFR and coronary artery calcification in the CRIC (Chronic Renal Insufficiency Cohort) Study. Am J Kidney Dis. 2011;58(4):519-26.
30. Detrano R. The ethnic-specific nature of mechanisms for coronary heart disease. J Am Coll Cardiol. 2003;41(1):45-6. (Pubitemid 36044402)
31. Elias-Smale SE, Proenca RV, Koller MT, Kavousi M, van Rooij FJ, Hunink MG, et al. Coronary calcium score improves classification of coronary heart disease risk in the elderly: the Rotterdam study. J Am Coll Cardiol. 2010;56(17):1407-14.
32. Greenland P, LaBree L, Azen SP, Doherty TM, Detrano RC. Coronary artery calcium score combined with Framingham score for risk prediction in asymptomatic individuals. JAMA. 2004;291 (2):210-5. (Pubitemid 38082815)
33. Kalsch H, Lehmann N, Mohlenkamp S, Neumann T, Slomiany U, Schmermund A, et al. Association of coronary artery calcium and congestive heart failure in the general population: results of the Heinz Nixdorf Recall study. Clin Res Cardiol. 2010;99(3):175-82.
34. Peters, S.A., M. Bakker, H.M. den Ruijter, and M.L. Bots, Added value of CAC in risk stratification for cardiovascular events: a systematic review. Eur J Clin Invest, 2012. 42(1): p. 110-6. This systemic review provides important information regarding the risk factors for coronary artery calcification.
35. Savoia, C., D. Burger, N. Nishigaki, A. Montezano, and R.M. Touyz, Angiotensin II and the vascular phenotype in hypertension. Expert Rev Mol Med, 2011. 13: p. e11. This review describes the roles of renin-angiotensin systems in VSMC growth, apoptosis, differentiation, and calcification.
36. Armstrong, Z.B., D.R. Boughner, M. Drangova, and K.A. Rogers, Angiotensin II type 1 receptor blocker inhibits arterial calcification in a pre-clinical model. Cardiovasc Res, 2011. 90(1): p. 165-70. This article provides evidence regarding the angiotensin receptor in the development of arterial calcification.
37. Tokumoto M, Mizobuchi M, Finch JL, Nakamura H, Martin DR, Slatopolsky E. Blockage of the renin-angiotensin system attenuates mortality but not vascular calcification in uremic rats: sevelamer carbonate prevents vascular calcification. Am J Nephrol. 2009;29(6):582-91.
38. Wu SY, Yu YR, Cai Y, Jia LX, Wang X, Xiao CS, et al. Endogenous aldosterone is involved in vascular calcification in rat. Exp Biol Med (Maywood). 2012;237(1):31-7.
39. Chen NX, Duan D, O'Neill D. K, and S.M. Moe, High glucose increases the expression of Cbfa1 and BMP-2 and enhances the calcification of vascular smooth muscle cells. Nephrol Dial Transplant. 2006;21(12):3435-42. (Pubitemid 44817092)
40. Al-Aly Z, Shao JS, Lai CF, Huang E, Cai J, Behrmann A, et al. Aortic Msx2-Wnt calcification cascade is regulated by TNFalpha- dependent signals in diabetic Ldlr-/- mice. Arterioscler Thromb Vasc Biol. 2007;27(12):2589-96. (Pubitemid 350158910)
41. Bostrom KI, Jumabay M, Matveyenko A, Nicholas SB, Yao Y. Activation of vascular bone morphogenetic protein signaling in diabetes mellitus. Circ Res. 2011;108(4):446-57.
42. Parhami F, Basseri B, Hwang J, Tintut Y, Demer LL. Highdensity lipoprotein regulates calcification of vascular cells. Circ Res. 2002;91(7):570-6.
43. Ting, T.C., S. Miyazaki-Anzai, M. Masuda, M. Levi, L.L. Demer, Y. Tintut, and M. Miyazaki, Increased lipogenesis and stearate accelerate vascular calcification in calcifying vascular cells. J Biol Chem, 2011. 286(27): p. 23938-49. This article provides evidence for lipid metabolism and lipogenesis as risk factors for vascular calcification.
44. Abedin M, Lim J, Tang TB, Park D, Demer LL, Tintut Y. N-3 fatty acids inhibit vascular calcification via the p38- mitogen-activated protein kinase and peroxisome proliferatoractivated receptor-gamma pathways. Circ Res. 2006;98 (6):727-9.
45. Parhami F, Morrow AD, Balucan J, Leitinger N, Watson AD, Tintut Y. Lipid oxidation products have opposite effects on calcifying vascular cell and bone cell differentiation. A possible explanation for the paradox of arterial calcification in osteoporotic patients. Arterioscler Thromb Vasc Biol. 1997;17(4):680-7. (Pubitemid 27169128)
46. Ridker PM. Clinical application of C-reactive protein for cardiovascular disease detection and prevention. Circulation. 2003;107 (3):363-9. (Pubitemid 36158034)
47. Kimmel PL, Phillips TM, Simmens SJ, Peterson RA, Weihs KL, Alleyne S, et al. Immunologic function and survival in hemodialysis patients. Kidney Int. 1998;54(1):236-44. (Pubitemid 28288040)
48. Oh J, Wunsch R, Turzer M, Bahner M, Raggi P, Querfeld U, et al. Advanced coronary and carotid arteriopathy in young adults with childhood-onset chronic renal failure. Circulation. 2002;106 (1):100-5. (Pubitemid 34747448)
49. Stompor T, Krasniak A, Sulowicz W, Dembinska-Kiec A, Janda K, Wojcik K, et al. Changes in common carotid artery intimamedia thickness over 1 year in patients on peritoneal dialysis. Nephrol Dial Transplant. 2005;20(2):404-12. (Pubitemid 40276899)
50. Aikawa E, Nahrendorf M, Figueiredo JL, Swirski FK, Shtatland T, Kohler RH, et al. Osteogenesis associates with inflammation in early-stage atherosclerosis evaluated by molecular imaging in vivo. Circulation. 2007;116(24):2841-50. (Pubitemid 350301146)
51. Tintut Y, Patel J, Parhami F, Demer LL. Tumor necrosis factoralpha promotes in vitro calcification of vascular cells via the cAMP pathway. Circulation. 2000;102(21):2636-42.
52. Tintut Y, Patel J, Territo M, Saini T, Parhami F, Demer LL. Monocyte/macrophage regulation of vascular calcification in vitro. Circulation. 2002;105(5):650-5. (Pubitemid 34123443)
53. Okazaki H, Shioi A, Hirowatari K, Koyama H, Fukumoto S, Ishimura E, et al. Phosphatidylinositol 3-kinase/Akt pathway regulates inflammatory mediators-induced calcification of human vascular smooth muscle cells. Osaka City Med J. 2009;55(2):71-80.
54. Amore A, Coppo R. Immunological basis of inflammation in dialysis. Nephrol Dial Transplant. 2002;17 Suppl 8:16-24. (Pubitemid 34918874)
55. Zoccali C, Mallamaci F, Tripepi G. Novel cardiovascular risk factors in end-stage renal disease. J Am Soc Nephrol. 2004;15 Suppl 1:S77-80. (Pubitemid 38018461)
56. Yamada, S., M. Taniguchi, M. Tokumoto, J. Toyonaga, K. Fujisaki, T. Suehiro, H. Noguchi, M. Iida, K. Tsuruya, and T. Kitazono, The antioxidant tempol ameliorates arterial medial calcification in uremic rats: Important role of oxidative stress in the pathogenesis of vascular calcification in chronic kidney disease. J Bone Miner Res, 2011. This study demonstrated that oxidative stress induced by uremia may play a role in the development of vascular calcification in CKD.
57. Sutra T, Morena M, Bargnoux AS, Caporiccio B, Canaud B, Cristol JP. Superoxide production: a procalcifying cell signalling event in osteoblastic differentiation of vascular smooth muscle cells exposed to calcification media. Free Radic Res. 2008;42 (9):789-97.
58. Liberman M, Bassi E, Martinatti MK, Lario FC, Wosniak Jr J, Pomerantzeff PM, et al. Oxidant generation predominates around calcifying foci and enhances progression of aortic valve calcification. Arterioscler Thromb Vasc Biol. 2008;28(3):463-70.
59. You H, Yang H, Zhu Q, Li M, Xue J, Gu Y, et al. Advanced oxidation protein products induce vascular calcification by promoting osteoblastic trans-differentiation of smooth muscle cells via oxidative stress and ERK pathway. Ren Fail. 2009;31(4):313-9.
60. Byon CH, Javed A, Dai Q, Kappes JC, Clemens TL, Darley- Usmar VM, et al. Oxidative stress induces vascular calcification through modulation of the osteogenic transcription factor Runx2 by AKT signaling. J Biol Chem. 2008;283 (22):15319-27.
61. Tintut Y, Parhami F, Tsingotjidou A, Tetradis S, Territo M, Demer LL. 8-Isoprostaglandin E2 enhances receptor-activated NFkappa B ligand (RANKL)-dependent osteoclastic potential of marrow hematopoietic precursors via the cAMP pathway. J Biol Chem. 2002;277(16):14221-6. (Pubitemid 34968036)
62. TsengW, Lu J, Bishop GA, Watson AD, Sage AP, Demer L, et al. Regulation of interleukin-6 expression in osteoblasts by oxidized phospholipids. J Lipid Res. 2010;51(5):1010-6.
63. Demer LL. Vascular calcification and osteoporosis: inflammatory responses to oxidized lipids. Int J Epidemiol. 2002;31(4):737-41. (Pubitemid 34947236)
64. Niwa T, Katsuzaki T, Miyazaki S, Miyazaki T, Ishizaki Y, Hayase F, et al. Immunohistochemical detection of imidazolone, a novel advanced glycation end product, in kidneys and aortas of diabetic patients. J Clin Invest. 1997;99(6):1272-80. (Pubitemid 27142764)
65. Miyata T, Sprague SM. Advanced glycation of beta 2- microglobulin in the pathogenesis of bone lesions in dialysisassociated amyloidosis. Nephrol, Dial, Transplant. 1996;11 Suppl 3:86-90. (Pubitemid 26278595)
66. Sakata N, Noma A, Yamamoto Y, Okamoto K, Meng J, Takebayashi S, et al. Modification of elastin by pentosidine is associated with the calcification of aortic media in patients with end-stage renal disease. Nephrol Dial Transplant. 2003;18 (8):1601-9. (Pubitemid 36939635)
67. Yamagishi S, Fujimori H, Yonekura H, Tanaka N, Yamamoto H. Advanced glycation endproducts accelerate calcification in microvascular pericytes. Biochem Biophys Res Commun. 1999;258 (2):353-7. (Pubitemid 29287055)
68. Tanikawa T, Okada Y, Tanikawa R, Tanaka Y. Advanced glycation end products induce calcification of vascular smooth muscle cells through RAGE/p38 MAPK. J Vasc Res. 2009;46(6):572-80.
69. Naka Y, Bucciarelli LG, Wendt T, Lee LK, Rong LL, Ramasamy R, et al. RAGE axis: Animal models and novel insights into the vascular complications of diabetes. Arterioscler Thromb Vasc Biol. 2004;24(8):1342-9. (Pubitemid 39050425)
70. Ren X, Shao H, Wei Q, Sun Z, Liu N. Advanced glycation endproducts enhance calcification in vascular smooth muscle cells. J Int Med Res. 2009;37(3):847-54.
71. Suga T, Iso T, Shimizu T, Tanaka T, Yamagishi S, Takeuchi M, et al. Activation of receptor for advanced glycation end products induces osteogenic differentiation of vascular smooth muscle cells. J Atheroscler Thromb. 2011;18(8):670-83.
72. Block GA, Hulbert-Shearon TE, Levin NW, Port FK. Association of serum phosphorus and calcium x phosphate product with mortality risk in chronic hemodialysis patients: a national study. Am J Kidney Dis. 1998;31(4):607-17.
73. Goodman WG, Goldin J, Kuizon BD, Yoon C, Gales B, Sider D, et al. Coronary-artery calcification in young adults with end-stage renal disease who are undergoing dialysis. N Engl J Med. 2000;342(20):1478-83. (Pubitemid 30318271)
74. Chertow GM, Burke SK, Raggi P. Sevelamer attenuates the progression of coronary and aortic calcification in hemodialysis patients. Kidney Int. 2002;62(1):245-52. (Pubitemid 34754068)
75. Tonelli M, Sacks F, Pfeffer M, Gao Z, Curhan G. Relation between serum phosphate level and cardiovascular event rate in people with coronary disease. Circulation. 2005;112 (17):2627-33. (Pubitemid 41532599)
76. Jono S, McKee MD, Murry CE, Shioi A, Nishizawa Y, Mori K, et al. Phosphate regulation of vascular smooth muscle cell calcification. Circ Res. 2000;87(7):E10-7.
77. Jono S, Peinado C, Giachelli CM. Phosphorylation of osteopontin is required for inhibition of vascular smooth muscle cell calcification. J Biol Chem. 2000;275(26):20197-203. (Pubitemid 30441631)
78. Steitz SA, Speer MY, Curinga G, Yang HY, Haynes P, Aebersold R, et al. Smooth muscle cell phenotypic transition associated with calcification: upregulation of Cbfa1 and downregulation of smooth muscle lineage markers. Circ Res. 2001;89(12):1147-54. (Pubitemid 34627872)
79. Werner A, Dehmelt L, Nalbant P. Na +-dependent phosphate cotransporters: the NaPi protein families. J Exp Biol. 1998;201 (Pt 23):3135-42. (Pubitemid 29020204)
80. Li X, Yang HY, Giachelli CM. Role of the sodium-dependent phosphate cotransporter, Pit-1, in vascular smooth muscle cell calcification. Circ Res. 2006;98(7):905-12.
81. Chen NX, O'Neill KD, Duan D, Moe SM. Phosphorus and uremic serum up-regulate osteopontin expression in vascular smooth muscle cells. Kidney Int. 2002;62(5):1724-31. (Pubitemid 35286280)
82. Chen, N.X., D. Duan, D. O'Neill K, G.O. Wolisi, J.J. Koczman, R. Laclair, and S.M. Moe, The mechanisms of uremic seruminduced expression of bone matrix proteins in bovine vascular smooth muscle cells. Kidney Int, 2006.
83. Hosaka N, Mizobuchi M, Ogata H, Kumata C, Kondo F, Koiwa F, et al. Elastin degradation accelerates phosphate-induced mineralization of vascular smooth muscle cells. Calcif Tissue Int. 2009;85(6):523-9.
84. Simionescu A, Philips K, Vyavahare N. Elastin-derived peptides and TGF-beta1 induce osteogenic responses in smooth muscle cells. Biochem Biophys Res Commun. 2005;334(2):524-32. (Pubitemid 40982398)
85. Lee KS, Kim HJ, Li QL, Chi XZ, Ueta C, Komori T, et al. Runx2 is a common target of transforming growth factor beta1 and bone morphogenetic protein 2, and cooperation between Runx2 and Smad5 induces osteoblast-specific gene expression in the pluripotent mesenchymal precursor cell line C2C12. Mol Cell Biol. 2000;20(23):8783-92. (Pubitemid 32245911)
86. Bouvet C, Moreau S, Blanchette J, de Blois D, Moreau P. Sequential activation of matrix metalloproteinase 9 and transforming growth factor beta in arterial elastocalcinosis. Arterioscler Thromb Vasc Biol. 2008;28(5):856-62. (Pubitemid 351544099)
87. Chen, N.X., Kalisha D. O'Neill, Xianming Chen Kiattisunthorn, Kraiwporn, Vincent H. Gattone and Sharon M. Moe, Activation of arterial matrix metalloproteinases leads to vascular calcification in chronic kidney disease. American Journal of Nephrology, 2011. Vol. 34(No. 3). This study suggests that matrix degradation plays an important role in vascular calcification in CKD.
88. Moe SM, Chertow GM. The Case against Calcium-Based Phosphate Binders. Clin J Am Soc Nephrol. 2006;1(4):697-703.
89. Yang H, Curinga G, Giachelli CM. Elevated extracellular calcium levels induce smooth muscle cell matrix mineralization in vitro. Kidney Int. 2004;66(6):2293-9. (Pubitemid 41115292)
90. Reynolds JL, Joannides AJ, Skepper JN, McNair R, Schurgers LJ, Proudfoot D, et al. Human vascular smooth muscle cells undergo vesicle-mediated calcification in response to changes in extracellular calcium and phosphate concentrations: a potential mechanism for accelerated vascular calcification in ESRD. J Am Soc Nephrol. 2004;15(11):2857-67. (Pubitemid 41103395)
91. Lomashvili KA, Cobbs S, Hennigar RA, Hardcastle KI, O'Neill WC. Phosphate-induced vascular calcification: role of pyrophosphate and osteopontin. J Am Soc Nephrol. 2004;15(6):1392-401. (Pubitemid 38679664)
92. Shroff, R.C., R. McNair, J.N. Skepper, N. Figg, L.J. Schurgers, J. Deanfield, L. Rees, and C.M. Shanahan, Chronic mineral dysregulation promotes vascular smooth muscle cell adaptation and extracellular matrix calcification. J Am Soc Nephrol, 2010. 21(1): p. 103-12. This study demonstrates an important role for calcium in VSMC calcification.
93. Kapustin AN, Davies JD, Reynolds JL, McNair R, Jones GT, Sidibe A, et al. Calcium regulates key components of vascular smooth muscle cell-derived matrix vesicles to enhance mineralization. Circ Res. 2011;109(1):e1-e12.
94. Wolf M. Fibroblast growth factor 23 and the future of phosphorus management. Curr Opin Nephrol Hypertens. 2009;18(6):463-8.
95. Kuro-o M, Matsumura Y, Aizawa H, Kawaguchi H, Suga T, Utsugi T, et al. Mutation of the mouse klotho gene leads to a syndrome resembling ageing. Nature. 1997;390(6655):45-51. (Pubitemid 27494749)
96. Balci M, Kirkpantur A, Gulbay M, Gurbuz OA. Plasma fibroblast growth factor-23 levels are independently associated with carotid artery atherosclerosis in maintenance hemodialysis patients. Hemodial Int. 2010;14(4):425-32.
97. Desjardins, L., S. Liabeuf, C. Renard, A. Lenglet, H.D. Lemke, G. Choukroun, T.B. Drueke, and Z.A. Massy, FGF23 is independently associated with vascular calcification but not bone mineral density in patients at various CKD stages. Osteoporos Int, 2011. This study demonstrates an important role for FGF23 in vascular calcification in CKD.
98. Stubbs J, Liu S, Quarles LD. Role of fibroblast growth factor 23 in phosphate homeostasis and pathogenesis of disordered mineral metabolism in chronic kidney disease. Semin Dial. 2007;20 (4):302-8.
99. El-Abbadi MM, Pai AS, Leaf EM, Yang HY, Bartley BA, Quan KK, et al. Phosphate feeding induces arterial medial calcification in uremic mice: role of serum phosphorus, fibroblast growth factor-23, and osteopontin. Kidney Int. 2009;75(12):1297-307.
100. Takei, Y., H. Yamamoto, T. Sato, A. Otani, M. Kozai, M. Masuda, Y. Taketani, K. Muto-Sato, B. Lanske, and E. Takeda, Stanniocalcin 2 is associated with ectopic calcification in alpha-klotho mutant mice and inhibits hyperphosphatemiainduced calcification in aortic vascular smooth muscle cells. Bone, 2012.